DR. OSAMUYIMEN O IGBINOSA MD
Prescription History 1386907921
Internal Medicine in Washington, DC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. OSAMUYIMEN O IGBINOSA MD, an active Internal Medicine specialist practicing in Washington, DC. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 68 documented patient claims. Among these therapy options, the most frequently utilized medication is Daptomycin, which accounts for 16 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other DC PrescribersVs. DC Avg |
|---|---|---|---|
| Daptomycin | 16 | $1,984.41 | ≈ Typical |
About Daptomycin: This medication is an antibiotic used to treat serious bacterial infections. Show more ▾ It works by stopping the growth of bacteria. Daptomycin is not recommended for use in children younger than 12 months due to possible risk of serious side effects. A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. In 2024, this provider wrote 16 Medicare prescriptions for Daptomycin, about the same volume as the typical District Of Columbia prescriber of this medication (17.7). Medicare paid an average of $1,984.41 per fill, versus $743.57 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 107 Days of Medication total across all patients in 2024 | |||
| JulucaDolutegravir/Rilpivirine | 16 | $3,695.90▼ below DC avg | ▼ Less than typical |
About Juluca: Dolutegravir/rilpivirine is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir is an integrase inhibitor while rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Both drugs block the virus from growing and infecting more cells. Dolutegravir/rilpivirine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. Combination of dolutegravir (an INSTI) plus rilpivirine (an NNRTI). In 2024, this provider wrote 16 Medicare prescriptions for Juluca, about half the volume of the typical District Of Columbia prescriber of this medication (31.8). Medicare paid an average of $3,695.90 per fill, versus $3,791.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| Isoniazid | 12 | $11.07 | – No State Data |
About Isoniazid: Isoniazid is used with other medications to treat active tuberculosis (TB) infections. Show more ▾ It is also used alone to prevent active TB infections in people who may be infected with the bacteria (people with positive TB skin test). Isoniazid is an antibiotic and works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. In 2024, this provider wrote 12 Medicare prescriptions for Isoniazid. Medicare paid an average of $11.07 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $11.07 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16.1 30-Day Fills standardized to 30-day supplies 457 Days of Medication total across all patients in 2024 | |||
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 12 | $5,464.07 | ▼ Less than typical |
About Symtuza: This product is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product contains 4 different medications: darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. Darunavir is known as a protease inhibitor. Cobicistat helps darunavir work better. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor; both kinds of drugs are often called NRTIs. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. Darunavir/co-bicistat/emtricitabina/tenofovir alafenamide combination drug. In 2024, this provider wrote 12 Medicare prescriptions for Symtuza, about a third of the volume of the typical District Of Columbia prescriber of this medication (28.9). Medicare paid an average of $5,464.07 per fill, versus $4,785.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| TivicayDolutegravir Sodium | 12 | $2,614.24 | ▼ Less than typical |
About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. An HIV integrase inhibitor that is used in the treatment of HIV INFECTIONS in combination with other ANTI-HIV AGENTS. In 2024, this provider wrote 12 Medicare prescriptions for Tivicay, about a quarter of the volume of the typical District Of Columbia prescriber of this medication (44.6). Medicare paid an average of $2,614.24 per fill, versus $2,531.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. OSAMUYIMEN O IGBINOSA MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Washington, DC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among DC prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
